v3.25.4
Derivatives - Schedule of Terminated Derivatives (Details)
Dec. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Instrument
Sep. 30, 2021
USD ($)
Instrument
Mar. 31, 2020
USD ($)
Instrument
Sep. 30, 2018
USD ($)
Instrument
Sep. 30, 2017
USD ($)
Instrument
Dec. 31, 2016
USD ($)
Instrument
Derivative [Line Items]              
Fair Value Deferred In Other Comprehensive Income $ 357,000            
Forward Swap              
Derivative [Line Items]              
Description | Instrument   2 2 3 2 2 2
Aggregate Notional Amount 200,000,000 [1] $ 200,000,000 $ 120,000,000 $ 200,000,000 $ 250,000,000 $ 250,000,000 $ 180,000,000
Liability Fair Value When Terminated [2]   409,000 1,584,000 13,141,000   7,690,000  
Asset Fair Value When Terminated [2]         (4,080,000)   (13,352,000)
Fair Value Deferred In Other Comprehensive Income $ 357,000 [3] $ 409,000 [4] $ 1,584,000 [4] $ 13,141,000 [4] $ (4,080,000) [4] $ 7,688,000 [4] $ (13,345,000) [4]
[1]

(2)

No hedge ineffectiveness was recognized during the year ended December 31, 2025.
[2]

(1)

The deferred liability (asset) is being amortized over the term of the hedged forecasted transaction using the effective interest method.

 
[3]

(1)

Included in other assets and other comprehensive income on the Consolidated Balance Sheets (see "Note 10 – Fair Value of Financial Instruments").

 
[4]

(2)

The amount reported in accumulated other comprehensive income (loss) will be reclassified to interest expense as interest payments are made on the related notes payable.